NuCana PLC Share Price Today: Live Updates & Key Insights

NuCana PLC share price today is $1.65, up -3.51%. The stock opened at $1.68 against the previous close of $1.71, with an intraday high of $1.74 and low of $1.65.

NuCana PLC Share Price Chart

NuCana PLC

us-stock
To Invest in {{usstockname}}
us-stock

NuCana PLC Share Price Performance

$1.65 -0.0351(-3.51%) NCNA at 23 Mar 2026 02:26 PM Biotechnology
Lowest Today 1.65
Highest Today 1.74
Today’s Open 1.68
Prev. Close 1.71
52 Week High 268.00
52 Week Low 1.63
Day’s Range: Low 1.65 High 1.74
52-Week Range: Low 1.63 High 268.00
1 day return -
1 Week return -13.54
1 month return -19.8
3 month return -51.88
6 month return -58.5
1 year return +121.33
3 year return -94.77
5 year return -98.81
10 year return -

NuCana PLC Institutional Holdings

The Carlyle Group Inc 3.20

Glass Jacobson Investment Advisors LLC 0.36

Jane Street Group LLC 0.27

UBS Group AG 0.25

LUNIS Biotech Growth Opp Fd I a 0.15

Rhumbline Advisers 0.12

Acadian Asset Management LLC 0.00

AllSquare Wealth Management LLC 0.00

Baader Bank INC 0.00

Cetera Investment Advisers 0.00

Flagstone Financial Management 0.00

Global Retirement Partners, LLC. 0.00

Morgan Stanley - Brokerage Accounts 0.00

SBI Securities Co Ltd 0.00

Tower Research Capital LLC 0.00

NuCana PLC Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

NuCana PLC Fundamentals

Market Cap 3.15 M

PB Ratio 0.2009

PE Ratio 0.0041

Enterprise Value -26.80 M

Total Assets 14.77 M

Volume 46231

NuCana PLC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:0 0.0M

Annual Net worth FY23:-35176000 -35.2M, FY22:-32021000 -32.0M, FY21:-40533000 -40.5M, FY20:-30682000 -30.7M, FY19:-21412000 -21.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-281000 -0.3M, Q2/2025:-24114000 -24.1M, Q1/2025:-2473000 -2.5M, Q3/2024:-4511000 -4.5M, Q2/2024:-6995000 -7.0M

About NuCana PLC & investment objective

Company Information NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom.

Organisation Biotechnology

Employees 20

Industry Biotechnology

CEO Mr. Hugh Stephen Griffith

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NuCana PLC FAQs

What is the share price of NuCana PLC today?

The current share price of NuCana PLC is $1.65.

Can I buy NuCana PLC shares in India?

Yes, Indian investors can buy NuCana PLC shares by opening an international trading and demat account with Motilal Oswal.

How to buy NuCana PLC shares in India?

You can easily invest in NuCana PLC shares from India by:

Can I buy fractional shares of NuCana PLC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NuCana PLC?

NuCana PLC has a market cap of $3.15 M.

In which sector does NuCana PLC belong?

NuCana PLC operates in the Biotechnology sector.

What documents are required to invest in NuCana PLC stocks?

To invest, you typically need:

What is the PE and PB ratio of NuCana PLC?

The PE ratio of NuCana PLC is 0.00 and the PB ratio is 0.20.